Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Treasury Shares: 2018-2024

Historic Treasury Shares for Bicycle Therapeutics (BCYC) over the last 4 years, with Dec 2024 value amounting to $674,262.

  • Bicycle Therapeutics' Treasury Shares rose 118.30% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year increase of 118.30%. This contributed to the annual value of $674,262 for FY2024, which is 106.29% up from last year.
  • Bicycle Therapeutics' Treasury Shares amounted to $674,262 in FY2024, which was up 106.29% from $326,848 recorded in FY2023.
  • Bicycle Therapeutics' 5-year Treasury Shares high stood at $674,262 for FY2024, and its period low was $187,725 during FY2022.
  • For the 3-year period, Bicycle Therapeutics' Treasury Shares averaged around $396,278, with its median value being $326,848 (2023).
  • Data for Bicycle Therapeutics' Treasury Shares shows a peak YoY skyrocketed of 106.29% (in 2024) over the last 5 years.
  • Over the past 3 years, Bicycle Therapeutics' Treasury Shares (Yearly) stood at $187,725 in 2022, then soared by 74.11% to $326,848 in 2023, then skyrocketed by 106.29% to $674,262 in 2024.